Literature DB >> 2418061

Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture.

F Arenzana-Seisdedos, S Barbey, J L Virelizier, M Kornprobst, C Nezelof.   

Abstract

We have investigated the secretory function of cell suspensions from bone eosinophilic granulomas surgically collected in two patients with histiocytosis X. Unseparated cell preparations spontaneously produced interleukin 1 (IL-1) and prostaglandin E2 (PGE2). In order to ascertain that this secretion was due to the characteristic Langerhans cell-like histiocytosis X cells predominantly found in the bone lesions, we have purified T6+ cells by the use of a fluorescence-activated cell sorter. Such highly purified cell preparations were found to secrete IL-1 and PGE2 spontaneously in culture. Stimulation with endotoxins and treatment with interferon gamma (IFN gamma) revealed an intense IL-1 secretory function of histiocytosis X cells. Since both IL-1 and PGE2 are able to induce bone resorption in vitro, our findings are compatible with the hypothesis that histiocytosis X cells are responsible for the typical osteolytic lesion observed in histiocytosis X through the local secretion of these two mediators.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418061      PMCID: PMC423345          DOI: 10.1172/JCI112296

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

Review 1.  Histiocytosis X histogenetic arguments for a Langerhans cell origin.

Authors:  C Nezelof; F Basset; M F Rousseau
Journal:  Biomedicine       Date:  1973-09

2.  Histiocytosis X: a histological and histogenetic study.

Authors:  C Nezelof
Journal:  Perspect Pediatr Pathol       Date:  1979

3.  The macrophage as an effector cell.

Authors:  C F Nathan; H W Murray; Z A Cohn
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

4.  Characterization of Langerhans cells by the use of monoclonal antibodies.

Authors:  G F Murphy; A K Bhan; S Sato; T J Harrist; M C Mihm
Journal:  Lab Invest       Date:  1981-11       Impact factor: 5.662

5.  Collagenolytic activity of eosinophilic granuloma in vitro.

Authors:  M F Rousseau-Merck; S Barbey; H Mouly; S Bazin; C Nezelof
Journal:  Experientia       Date:  1979-09-15

6.  Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells.

Authors:  J M Dayer; J Bréard; L Chess; S M Krane
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

7.  Prostaglandins in histiocytosis-X. PG synthesis by histiocytosis-X cells.

Authors:  F Gonzalez-Crussi; W Hsueh; M D Wiederhold
Journal:  Am J Clin Pathol       Date:  1981-02       Impact factor: 2.493

8.  Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

Authors:  S B Mizel; J M Dayer; S M Krane; S E Mergenhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  Monocytes regulate osteoclast-activating factor production by releasing prostaglandins.

Authors:  T Yoneda; G R Mundy
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

10.  Lymphokine-mediated bone resorption requires endogenous prostaglandin synthesis.

Authors:  R S Bockman; M A Repo
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  14 in total

1.  Endocrine aspects of Langerhans cell histiocytosis.

Authors:  A T Soliman; I Alsalmi; N E Banna; M Asfour
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Defective alloantigen-presenting capacity of 'Langerhans cell histiocytosis cells'.

Authors:  R C Yu; J F Morris; J Pritchard; T C Chu
Journal:  Arch Dis Child       Date:  1992-11       Impact factor: 3.791

3.  Langerhans cell histiocytosis in monocygote twins: case reports.

Authors:  I Mader; K W Stock; E W Radue; W Steinbrich
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

4.  IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy.

Authors:  Ichiro Murakami; Akira Morimoto; Takashi Oka; Satoshi Kuwamoto; Masako Kato; Yasushi Horie; Kazuhiko Hayashi; Jean Gogusev; Francis Jaubert; Shinsaku Imashuku; Lamia Abd Al-Kadar; Katsuyoshi Takata; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2012-12-27       Impact factor: 4.064

5.  Langerhans cell histiocytosis--clinical and epidemiological aspects.

Authors:  V Broadbent; R M Egeler; M E Nesbit
Journal:  Br J Cancer Suppl       Date:  1994-09

6.  Eosinophilic granuloma of the orbit: a paradox of aggressive destruction responsive to minimal intervention.

Authors:  Gerald J Harris; Kyung In Woo
Journal:  Trans Am Ophthalmol Soc       Date:  2003

7.  Expression of prostaglandin H synthase (cyclooxygenase) in Hodgkin's mononuclear and Reed-Sternberg cells. Functional resemblance between H-RS cells and histiocytes or interdigitating reticulum cells.

Authors:  S M Hsu; P L Hsu; S S Lo; K K Wu
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

8.  Functional defect in cells involved in Langerhans cell histiocytosis.

Authors:  R C Yu; M Alaibac; A C Chu
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 9.  The role of cytokines in the pathogenesis of Langerhans cell histiocytosis.

Authors:  G Kannourakis; A Abbas
Journal:  Br J Cancer Suppl       Date:  1994-09

10.  Management of eosinophilic granuloma occurring in the appendicular skeleton in children.

Authors:  Ilkyu Han; Eun Seok Suh; Sang-Hoon Lee; Hwan Seong Cho; Joo Han Oh; Han-Soo Kim
Journal:  Clin Orthop Surg       Date:  2009-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.